Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03445559 · ClinicalTrials.gov registry record · NA
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
A NA study of Prostate Cancer, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 11
- Study locations
NCT03445559: Active NA study of Prostate Cancer, sponsored by VA Office of Research and Development.
NCT03445559 is a NA study of Prostate Cancer that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 58 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03445559, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging imaging. Other aims of this study include to use mixed methods to explore physician influence on guideline-concordant imaging and to determine the cost and cost impact of a physician-focused behavioral intervention to improve guideline-concordant prostate cancer imaging.
Primary Outcome
Facility-level utilization of bone scan imaging among men with newly diagnosed, low-risk prostate cancer. (Inappropriate Imaging according to NCCN guidelines)
Conditions Studied
Interventions
- BEHAVIORAL Clinical Order Check
- BEHAVIORAL Academic Detailing
- BEHAVIORAL Audit and Feedback
Study Locations (11)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
New York
- VA NY Harbor Healthcare System, New York, NY - New York
- Syracuse VA Medical Center, Syracuse, NY - Syracuse
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What the registry record for NCT03445559 still lists
NCT03445559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Clinical Order Check is the first listed.
NCT03445559 lists 11 locations in 9 states (California, New York, Connecticut).
Frequently Asked Questions
What is clinical trial NCT03445559 about?
NCT03445559 is a clinical study titled "A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging". The primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging imaging. Other aims of this study include to use mixed methods to explore physician influence on guide...
What is the current status of trial NCT03445559?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2018-04-09. Estimated completion is 2027-02-28.
What conditions does trial NCT03445559 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03445559?
The interventions under investigation include: Clinical Order Check (BEHAVIORAL), Academic Detailing (BEHAVIORAL), Audit and Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03445559?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03445559 being conducted?
This trial has 11 study locations across California, Connecticut, Minnesota, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03445559's enrollment target sits among peer trials
58 447th of 735 higher than 285 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI